P803 The risk of spine and hip fracture in patients with inflammatory bowel diseases: a nationwide population-based study
ECCO'20 Vienna
2020
P805 Patients with Crohn’s disease treated with ustekinumab vs. vedolizumab in real-world settings
ECCO'20 Vienna
2020
P806 Increasing incidence of microscopic colitis in a population-based cohort study in a French speaking region of Switzerland
ECCO'20 Vienna
2020
P807 UCEIS is associated with PRO2, partial Mayo and SCCAI remission in UC: preliminary results from a prospective study
ECCO'20 Vienna
2020
P808 Prevalence and factors associated with sleep disturbances in inflammatory bowel disease patients compared with normal controls
ECCO'20 Vienna
2020
P809 Increase of tuberculosis due to combination therapy in inflammatory bowel disease: a nationwide population-based study in Korea
ECCO'20 Vienna
2020
P810 Geriatric impairments in older inflammatory bowel disease patients are associated with higher disease burden: results of a multicentre cohort study
ECCO'20 Vienna
2020
P811 A watchful approach for newly diagnosed Crohn’s disease patients with an inflammatory phenotype
ECCO'20 Vienna
2020
P812 Inflammatory bowel disease and hepatopathies: Beyond primary sclerosing cholangitis
ECCO'20 Vienna
2020
P815 Are hospitalised patients with inflammatory bowel disease at increased risk of invasive bacterial infections? Results from POLIBD 2-year cohort study
ECCO'20 Vienna
2020
P816 Association of autoimmune rheumatic disease with inflammatory bowel disease: a nationwide population-based study
ECCO'20 Vienna
2020
P817 Influence of inflammatory bowel diseases on depression and suicidal risk: a questionnaire-based survey
ECCO'20 Vienna
2020
P818 Venous thromboembolism is rare among hospitalised patients with an inflammatory bowel disease flare: a multicentre retrospective cross-sectional study
ECCO'20 Vienna
2020
P819 Seroprevalence of Borrelia burgdorferi antibodies in patients with ulcerative colitis
ECCO'20 Vienna
2020
P820 An easy and rapid targeted next generation sequencing-based genotyping assay for the validated IBD risk loci
ECCO'20 Vienna
2020